This office extends Criterium’s worldwide clinical trials capabilities into Russia, the former Soviet Republics and Eastern European States. The following services will be offered in conjunction with Criterium’s global full-service contract-research resources:
The Russian and Eastern European region has proven itself to be increasingly popular with worldwide developers of pharmaceutical, biotech, and medical-devices. They have increased the number of international multicenter trials in which this region participates by over 400% since 1998. There remains a large opportunity here for future expansion.
The region is characterized by a strong medical system, universities and academic centers, specialized hospitals and European standards-compliant legislation, a large contingent of well-trained and highly skilled medical personnel, and a history of ICH/GCP compliance.
There is a large potential patient population pool for many therapeutic areas that are not able to have access to modern current treatments and therefore are prime candidates to enroll in clinical discovery programs.